Carla Marisa Pacheco Magalhães

Mrs. Carla Marisa Pacheco Magalhães

University of Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 August 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
ANAra Núñez-Montenegro
Ara Núñez-Montenegro
PFPaulo J.O. Ferreira
Paulo J.O. Ferreira
Diana Sousa DuarteDiana Sousa Duarte
Diana Sousa Duarte
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Cancer is a very challenging disease to treat, both in terms of treatment efficiency and side-effects. To overcome these problems, there have been extensive studies regarding the possibility of improving treatment by employing combination therapy, and by exploring therapeutic modalities with reduced side-effects (such as photodynamic therapy (PDT)). Herein, this work has two aims: (i) to develop self-activating photosensitizers for use in light-free photodynamic therapy, which would eliminate light-related restrictions that this therapy currently possesses; (ii) to assess their co-treatment potential when combined with reference chemotherapeutic agents (Tamoxifen and Metformin). We synthesized three new photosensitizers capable of self-activation and singlet oxygen production via a chemiluminescent reaction involving only a cancer marker and without requiring a light source. Cytotoxicity assays demonstrated the cytotoxic activity of all photosensitizers for prostate and breast tumor cell lines. Analysis of co-treatment effects revealed significant improvements for breast cancer, producing better results for all combinations than just for the individual photosensitizers and even Tamoxifen. By its turn, co-treatment for prostate cancer only presented better results for one combination than for just the isolated photosensitizers and Metformin. Nevertheless, it should be noted that the cytotoxicity of the isolated photosensitizers in prostate tumor cells was already very appreciable.

1 January 2019 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva

1 December 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
ANAra Núnez-Montenegro
Ara Núnez-Montenegro
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
PFPaulo J.O. Ferreira
Paulo J.O. Ferreira
Diana Sousa DuarteDiana Sousa Duarte
Diana Sousa Duarte
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva

9 August 2017 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva
RPRui Pereira
Rui Pereira
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva

1 July 2018 in Journal of Luminescence
Verified
Journal Article
Closed access
Carla Marisa Pacheco MagalhãesCarla Marisa Pacheco Magalhães
Carla Marisa Pacheco Magalhães
Joaquim C.G. Esteves Da SilvaJoaquim C.G. Esteves Da Silva
Joaquim C.G. Esteves Da Silva
Luís Pinto da SilvaLuís Pinto da Silva
Luís Pinto da Silva